Stockscreener 앱 받기
2.5758
3.17%
-0.1042
전일 마감가:
$2.68
열려 있는:
$2.68
하루 거래량:
174.96K
Relative Volume:
0.06
시가총액:
$442.98M
수익:
$7.25M
순이익/손실:
$-17.41M
주가수익비율:
-9.8051
EPS:
-0.2627
순현금흐름:
$-38.33M
1주 성능:
-10.82%
1개월 성능:
+7.23%
6개월 성능:
+59.20%
1년 성능:
+670.49%
1일 변동 폭
$2.56
$2.6899
1주일 범위
$2.575
$2.97
52주 변동 폭
$0.2701
$3.105
Ovid Therapeutics Inc Stock (OVID) Company Profile
명칭
Ovid Therapeutics Inc
전화
212-776-4381
주소
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Compare OVID vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
2.56 | 463.74M | 7.25M | -17.41M | -38.33M | -0.2627 |
VRTX
Vertex Pharmaceuticals Inc
|
430.18 | 110.67B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.86 | 80.98B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
781.13 | 49.00B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
305.63 | 41.87B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.80 | 33.28B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 개시 | Roth Capital | Buy |
| 2025-11-17 | 개시 | Leerink Partners | Outperform |
| 2025-10-09 | 개시 | Oppenheimer | Outperform |
| 2025-08-08 | 재개 | B. Riley Securities | Buy |
| 2024-06-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-04-30 | 개시 | B. Riley Securities | Buy |
| 2024-04-29 | 개시 | H.C. Wainwright | Buy |
| 2024-04-05 | 개시 | Wedbush | Outperform |
| 2023-12-21 | 개시 | BTIG Research | Buy |
| 2023-10-13 | 개시 | Oppenheimer | Outperform |
| 2021-04-20 | 다운그레이드 | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | 개시 | RBC Capital Mkts | Outperform |
| 2018-04-20 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Ovid Therapeutics Inc 주식(OVID)의 최신 뉴스
OVID Ovid Therapeutics Inc. far exceeds Q4 2025 EPS expectations, shares rise nearly four percent.Profit Guidance - Cổng thông tin điện tử Tỉnh Sơn La
OVID (Ovid Therapeutics) delivers blowout Q4 2025 results, but stock dips slightly amid mild investor profit taking.Deceleration Risk - Xã Thanh Hà
29.86M-share resale registration by Ovid Therapeutics (NASDAQ: OVID) - Stock Titan
H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy By Investing.com - Investing.com India
Ovid Therapeutics receives $53.9 million from warrant exercises By Investing.com - Investing.com India
Ovid Therapeutics Boosts Capital Through Warrant Exercises - TipRanks
Ovid Therapeutics receives $53.9 million from warrant exercises - Investing.com
Ovid Therapeutics sees $53.9M gross proceeds as Series A warrants mostly exercised - TradingView
Warrant exercises bring Ovid Therapeutics (NASDAQ: OVID) $53.9M cash - Stock Titan
H.C. Wainwright reiterates Ovid Therapeutics stock rating at buy - Investing.com
William Blair Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Announces Target Price $5.24 - 富途牛牛
LifeSci Capital Maintains Ovid Therapeutics(OVID.US) With Buy Rating, Maintains Target Price $5 - Moomoo
William Blair Maintains Ovid Therapeutics(OVID.US) With Buy Rating - 富途牛牛
OVID.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OVID Reiterated by Wedbush -- Price Target Maintained at $7.00 - GuruFocus
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential By Investing.com - Investing.com South Africa
Leerink reiterates Ovid Therapeutics stock rating on KCC2 potential - Investing.com
Ovid Therapeutics' (OVID) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS DisordersSlideshow - Seeking Alpha
Value Recap: What hedge funds are buying Ovid Therapeutics Inc2026 Analyst Calls & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
VIX Spike: Does Ovid Therapeutics Inc have declining or rising EPS2026 Analyst Calls & Risk Controlled Swing Alerts - baoquankhu1.vn
HC Wainwright Issues Positive Forecast for OVID Earnings - MarketBeat
Whale Trades: What are Ovid Therapeutics Incs growth levers2026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn
OVID Should I Buy - Intellectia AI
H.C. Wainwright raises Ovid Therapeutics stock price target to $4 By Investing.com - Investing.com Australia
[Form 4] Ovid Therapeutics Inc. Insider Trading Activity - Stock Titan
Ovid Therapeutics (NASDAQ: OVID) director granted RSUs in lieu of cash pay - Stock Titan
Director Kevin Fitzgerald awarded Ovid Therapeutics (OVID) RSU compensation - Stock Titan
Trade Recap: Why is Ovid Therapeutics Inc stock going up2026 Top Gainers & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Ovid Therapeutics Surge: Positive Phase 1 Data Ignites Market Confidence - timothysykes.com
Ovid Therapeutics (OVID): HC Wainwright & Co. Raises Price Targe - GuruFocus
H.C. Wainwright raises Ovid Therapeutics stock price target to $4 - Investing.com
Big Money Moves: Why is Ovid Therapeutics Inc stock going up - baoquankhu1.vn
Ovid Therapeutics Inc. (OVID) stock price, news, quote and history - Yahoo Finance UK
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14 - The Manila Times
Ovid Therapeutics Shares Surge After Positive Phase 1 Results and Financing News - StocksToTrade
Earnings Report: Is Ovid Therapeutics Inc being accumulated by smart money2026 Breakouts & Breakdowns & Fast Gain Stock Tips - baoquankhu1.vn
Is Ovid Therapeutics (OVID) Stock Trending Up | Price at $2.31, Up 4.77%Open Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
Ovid Therapeutics Inc (OVID) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
OVID.O Technical Analysis & Stock Price Forecast - Intellectia AI
OVID News & Events - intellectia.ai
IPO Launch: Does Ovid Therapeutics Inc have declining or rising EPSWeekly Trend Recap & Daily Growth Stock Investment Tips - baoquankhu1.vn
Gains Report: Can Ovid Therapeutics Inc maintain its current growth rate2026 Opening Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Ovid Therapeutics (OVID) price target increased by 14.29% to 4.87 - MSN
Rate Hike: Is Ovid Therapeutics Inc still a buy after recent gains2026 Chart Watch & High Accuracy Trade Alerts - baoquankhu1.vn
OVID Therapeutics Inc (NASDAQ:OVID) Passes Minervini's High-Growth Momentum and Trend Template Filters - ChartMill
Aug Reactions: How does Ovid Therapeutics Inc score in quality rankingsCEO Change & Weekly Stock Performance Updates - baoquankhu1.vn
Ovid Therapeutics Inc (OVID) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ovid Therapeutics Inc 주식 (OVID) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ALEXANDER MARGARET A. | President and CEO |
Feb 23 '26 |
Sale |
1.45 |
11,656 |
16,901 |
61,750 |
| Rona Jeffrey A | CBFO |
Feb 23 '26 |
Sale |
1.45 |
8,541 |
12,384 |
88,188 |
1.76%
0.18%
자본화:
|
볼륨(24시간):